Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Omburtamab I-124 |
Trade Name | |
Synonyms | Iodine I 124 Omburtamab|Iodine I 124 MOAB 8H9 |
Drug Descriptions |
Omburtamab I-124 is a B7-H3 (CD276) glycoprotein targeting monoclonal antibody radiolabeled with Iodine 124, which has potential antitumor activity against CD276-expressing tumor cells (PMID: 31405921; J Clin Oncol. 37, no. 15_suppl). |
DrugClasses | CD276 Antibody 16 |
CAS Registry Number | NA |
NCIT ID | C99632 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Omburtamab I-124 | Omburtamab I-124 | 0 | 1 |